logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

 

Equities – Your destination to connect with the growth investment community.

Pfizer Tops Estimates in Second Quarter, Reiterates Full Year Outlook

By  +Follow July 30, 2013 8:52AM
Share:
Tickers Mentioned:

Pfizer Inc. (PFE) , the biggest drugmaker in the world, on Tuesday reported second-quarter earnings that nipped past analyst predictions as the company fought through declining sales that were hamstringed by the loss of exclusivity on the blockbuster cholesterol fighter Lipitor.

For the quarter, NYC-based Pfizer said it generated $12.97 billion in revenue, compared to $13.97 billion in the second quarter last year.  Net income soared to $14.1 billion, or $1.98 per share, versus $3.25 billion, or 43 cents per share, in last year’s quarter.  In February, Pfizer spun-out its animal health business into a new company called Zoetis, Inc. (ZTS) .  In December 2012, it sold its nutrition business to Nestle SA ($NSRGY) for $11.85 billion, accounting for most of the surge in reported income.  Excluding gains from the sale, restructuring costs and other special items, adjusted profits for the second quarter totaled $4.0 billion, or 56 cents per share, compared to $4.45 billion, or 59 cents per share, in the year prior quarter.

Wall Street was expecting EPS of 55 cents on revenue of $13.01 billion.

Sales of Lipitor sank 55 percent from $1.22 billion in the second quarter of 2012 to $545 million in the latest quarter.  Sales of pneumococcal vaccine Prevnar slipped 3 percent to $969 million due to changes in government purchasing patterns.  Counterbalancing those losses, sales of Pfizer’s biggest drug Lyrica, which is indicated for fibromyalgia, diabetic nerve pain and more, improved by 10 percent to $1.13 billion.

Revenue for Pfizer’s leading business units – primary care, specialty care, emerging markets and established products – all declined compared to the year prior quarter.  Ian Read, chairman and chief executive at Pfizer, said in today’s statement that he expects emerging market business growth to accelerate in the second of the year, led by China.

“From a total company view, we are tracking to our expectations for the full year and continue to capitalize on the investments we are making to better position Pfizer for long-term success,” added Read.

The company backed its 2013 forecast of adjusted earnings in the range of $2.10 to $2.20 per share.

Sales of anti-cancer drugs rose 24 percent to $399 million, boosted in part by a 191-percent climb in sales of Xalkori to $67 million and $17 million in sales from new drug Inlyta.

Operating margin improved significantly from 29.9 percent to 41.3 percent.

Marking “the next step in Pfizer’s journey to further revitalize [its] innovative core,” Pfizer said on Monday that it intends to split its company into three new units.  One unit will focus on drugs that are patent-protected beyond 2015.  The second will include vaccines, oncology and consumer healthcare products.  The third will include drugs that have lost – or will soon lose – patent exclusivity, generics and future product collaborations.  The changes are slated to start happening in January.

Two new drugs, blood thinner Eliquis and rheumatoid arthritis drug Xeljanz, are thought by many to have the capabilities to grow into blockbusters, although Zeljanz is facing some hurdles in Europe with negative opinions being offered by a European Medicines Agency committee.  Zeljanz generated $33 million in sales in the second quarter. The FDA is reviewing a supplemental New Drug Application (NDA) for Zeljanz with a decision expected by February.  Topline results are expected from two ongoing phase 3 trials evaluating Zeljanz in the second quarter next year.  The FDA is also reviewing a supplemental NDA for Eliquis, with a decision expected by March 15, 2014. 

During the second quarter, Pfizer repurchased $3.3 billion worth of its common stock, bringing its first-half total to $8.7 billion.

Shares of PFE have risen 20 percent so far in 2013 through Monday’s close at $29.54.  

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Liked What You Read? Join Equities.com and Connect With Your Favorite Financial Experts FOR FREE! Members of Equities.com gain access to our leading financial news and content, active social investment community, proprietary research tools including the 2014 Small-Cap Stars, E.V.A. reports and more.

Results for PFE
VANDERSCHELDEN
25 Apr 15 08:12:13
... So ... $PFE... "It's INNATE Pharma who SAVE... ASTRA ZENECA... ;-)))... "Surtout, elle se dit ravie de participe…https://t.co/86SJaQ6klN
MAISA
25 Apr 15 08:01:17
#Week13: $MNKD #Afrezza got 1,431TRx YTD = AVE ~110.07/wk $PFE #EXUBERA got 1,665TRx YTD = AVE ~128.07/wk Winner is #Exubera! No brainer!
MAISA
25 Apr 15 07:55:49
$MNKD #Afrezza got 1,431 TRx YTD for 13 weeks =AVE ~110.07/wk $PFE #Exubera got 11,787 TRx for 28 weeks =AVE ~420.96/wk Winner is #Exubera
IH News Desk
25 Apr 15 07:52:07
$GE Reviews Updated Saturday, April 25, 2015 10:10:56 AM $ARRY $BP $FXI $PFE http://t.co/lEZBB3QjDH
IH News Desk
25 Apr 15 06:51:23
$MTL News Updated Saturday, April 25, 2015 09:10:55 AM $UUP $FXI $RHT $PFE http://t.co/qVXirzUFTw
PolgarStocks
25 Apr 15 06:34:42
$ATVI Investor Opinions Updated Saturday, April 25, 2015 09:07:05 AM $PFE $WFM $WMIH $EA http://t.co/6TGQuIGTA0
PolgarStocks
25 Apr 15 06:34:39
$XLU Short Sales Updated Saturday, April 25, 2015 09:07:05 AM $EFA $PFE $CVX $XHB http://t.co/9E68Cj779M
royfberger
25 Apr 15 05:06:06
Unreal SKY tonight $MAT $TSM $IWM $PFE $DRC $LVS $CL $WTW $APC $GDX http://t.co/JUFJoVvAWo http://t.co/zjEOetHdXQ
Stock_Tracker
25 Apr 15 04:42:06
Stocks Trending Now: http://t.co/3L8CEGgR78 $ADMD $FCAU $CHOP $BAGR $FCS $TILE $ICPT $SAMP $PKX $PFE $PTX $TWOU ~
Rosner Stocks
25 Apr 15 04:30:41
$PIO Short Sales Updated Saturday, April 25, 2015 06:59:24 AM $TNA $XLB $NEM $PFE http://t.co/h9rvl0i3TP
NASDAQ
25 Apr 15 04:11:17
$PFE - Are Biosimilars the Next Big Thing in Biotech? http://t.co/S3BBV53O5P
Solo traders
25 Apr 15 04:11:17
$PFE - Are Biosimilars the Next Big Thing in Biotech? http://t.co/WwYP2LQ6N3
StockNews
25 Apr 15 04:11:09
$PFE - Are Biosimilars the Next Big Thing in Biotech? http://t.co/ckEbuVSdAm
James DiPlata
25 Apr 15 04:05:19
RT @DozenStocks: Weekly Dow #Stocks Trend $MSFT $IBM $MCD $DIS $VZ $AAPL $CAT $JNJ $PFE $V $CSCO $NKE $UNH $CVX $GS $DD $JPM $XOM @ http://…
PolgarStocks
25 Apr 15 03:31:41
$IBB Company Info Updated Saturday, April 25, 2015 06:07:03 AM $PFE $EWH $PBR $MCP http://t.co/ZgV5BUEdMo
PharmaCompass
25 Apr 15 03:30:21
Daichi just got out of Ranbaxy, $MYL announcing three recalls in less than a month! Will Teva have a similar experience as $PFE with $HSP?
Beverage Consulting
25 Apr 15 03:05:11
RT @MarathonWealth: (US 4/16) S&P 500: -0.08% GREEN: $DD $BAC $DIS $KO RED: $SPY $XOM $CVX $T $VZ $JPM $WFC $V $MA $PEP $IBM $TXN $M $MMM $…
12Stocks.com
25 Apr 15 03:01:16
Weekly Dow #Stocks Trend $MSFT $IBM $MCD $DIS $VZ $AAPL $CAT $JNJ $PFE $V $CSCO $NKE $UNH $CVX $GS $DD $JPM $XOM @ http://t.co/TvzJfd0RGT
IH News Desk
25 Apr 15 01:48:05
$BIIB News Updated $WFC $BIDU $GOOG $PFE http://t.co/4FvYuG1Jlo
PolgarStocks
25 Apr 15 01:29:11
$XLI Stock Forum Updated $EA $F $PFE $PIO http://t.co/DoyAGH182h
Hung Tran, MS, MD
25 Apr 15 01:18:02
The MD-360 Reports on Corporate Strategy of Pfizer and Hospira Acquisition Deal https://t.co/afYZ0HZzJ5 $PFE
IH News Desk
25 Apr 15 00:48:15
$ARIA News Updated $PFE $WMIH $ARIA $NUGT http://t.co/hYFIq6u9np
Invest | Donate
24 Apr 15 23:44:07
@rosnerstocks: $NUS Exchange Click Here: http://t.co/RmWjnGa2Jx Also See: $CE $PFE $QSR $FXCM #stockmarket #invest #stocks ~
Rosner Stocks
24 Apr 15 23:25:38
$PFE Financials Updated $NFLX $IHI $RDSH $AMZN http://t.co/u4M0dbgEls
Rosner Stocks
24 Apr 15 23:21:33
$NUS Exchange Click Here: http://t.co/WkagYtqL5o Also See: $CE $PFE $QSR $FXCM #stockmarket #invest #stocks ~
James DiPlata
24 Apr 15 22:51:08
RT @DozenStocks: Dow #Stocks Trend $MSFT $MCD $DIS $VZ $IBM $AAPL $JNJ $CAT $PFE $V $CSCO $NKE $UNH $DD $CVX $JPM $GS $XOM $GE @ http://t.…
Bradley
24 Apr 15 22:07:06
Find your own trading path. $MAT $TSM $IWM $PFE $GOOG $AAPL $DRC $LVS $CL $WTW $APC $GDX http://t.co/l9JkTCtpHR http://t.co/D1v0xY3x1K
$PVCT
24 Apr 15 21:52:03
$PVCT to pair w PD1s/L1s, combo bodes well for #cancer patients! #autoimmune #immunotherapy $gsk $bmy $mrk $pfe http://t.co/xa1BiOOYzq
12Stocks.com
24 Apr 15 21:51:49
Dow #Stocks Trend $MSFT $MCD $DIS $VZ $IBM $AAPL $JNJ $CAT $PFE $V $CSCO $NKE $UNH $DD $CVX $JPM $GS $XOM $GE @ http://t.co/TvzJfd0RGT
IH News Desk
24 Apr 15 21:45:12
$PFE Filings Updated Friday, April 24, 2015 12:11:06 PM $MCP $VLTC $SLV $IGN http://t.co/u57kmcGLip
IH News Desk
24 Apr 15 21:45:08
$TBT Opinions Updated Friday, April 24, 2015 12:11:06 PM $PFE $BIIB $FDN $INCC http://t.co/guRSvEJ2jr
Dow Stocks
24 Apr 15 21:42:05
#Dow #stocks $PFE Pfizer Daily:-0.25% Weekly:0.66% YTD:14.22% Trend:90 / 100 http://t.co/eX04HByJ2u
12Stocks.com
24 Apr 15 21:35:59
Weekly Dow #Stocks Trend $MSFT $IBM $MCD $DIS $VZ $AAPL $CAT $JNJ $PFE $V $CSCO $NKE $UNH $CVX $GS $DD $JPM $XOM @ http://t.co/TvzJfd0RGT
Jeff Sandene, CFP®
24 Apr 15 21:31:15
US 4/24 S&P 500: +0.23% GREEN: $SPY $DD $TXN $CMG $JNJ $DIS $MCD $PG $KR $SHW $LUV RED: $XOM $V $MA $M $WFC $JPM $BAC $IBM $PEP $PFE $KO $GE
Langan Stocks
24 Apr 15 20:57:54
Stocks Trending Now: http://t.co/TkLSaytau1 $CNCO $CRMD $CBK $PFE $POT $MAS $GOOGL $MU $CAKE $LLY $COL $TNAV ~
Stock_Tracker
24 Apr 15 20:29:12
Stocks Trending Now: http://t.co/3L8CEFZgfA $PTIE $NEOG $PGTI $CAKE $NMR $LRCX $SIGM $SPPR $GEVA $MU $IGRW $PFE ~
Sam
24 Apr 15 19:56:05
One more before bed! Love ya'll! $MAT $TSM $IWM $PFE $DRC $LVS $CL $WTW $APC $GDX http://t.co/YU579z0Ece http://t.co/QbKlcbSuFu
$PVCT
24 Apr 15 19:44:45
RT @alanrobertross: $PFE article http://t.co/ttJxL5eH6C '#PV10 made 4 use w/immune down-regulators anti-CTLA-4, PD-1/PD-L1 &up-regulators I…
Douglas Allan
24 Apr 15 19:33:22
@ohmsonite @Drchik23 @psuvafan007 $PFE owns $25mil of $CLDN and have revenue of $46Bil $CLDN failure not of financial consequence to them.
$PVCT
24 Apr 15 18:58:04
RT @jeanie93: $PVCT and $PFE Receive Pat Allowance for PV-10 Therapy in Combination with Systemic Immunotherapy For Melanoma Treat http://t…
Clayton R.
24 Apr 15 18:29:07
Wondering where to learn stock options? Here's the place http://t.co/gV3ZaHH3uy $F $GE $T $BAC $VZ $C $AA $JPM $KO $PFE #investing
Joe
24 Apr 15 18:26:29
@psuvafan007 Good Q. Also, will it effect $qure more than others? How about the big boys who've invested in it, like $pfe, 10% holders?
Langan Stocks
24 Apr 15 17:21:20
$SLTD Opinions Updated Friday, April 24, 2015 8:03:11 PM $PFE $FDN $VDSI $GILD http://t.co/P4cq2c4vMN
royfberger
24 Apr 15 16:09:07
Unreal SKY tonight $MAT $TSM $IWM $PFE $DRC $LVS $CL $WTW $APC $GDX http://t.co/JUFJoVvAWo http://t.co/l7vQZiDDCz
12Stocks.com
24 Apr 15 16:01:15
Dow #Stocks Trend $MSFT $MCD $DIS $VZ $IBM $AAPL $JNJ $CAT $PFE $V $CSCO $NKE $UNH $DD $CVX $JPM $GS $XOM $GE @ http://t.co/TvzJfd0RGT
#HelpYouGetGAINS
24 Apr 15 15:32:56
Dogs Of The Dow March Quarter Roundup http://t.co/Aj1WrOI39Q … $DIA $MCD $CAT $HSP $PFE $AMT
Sentiquant
24 Apr 15 15:00:05
#sentishiftup $NETE $XLY $ANY $DJIA $PFE $CSCO $STJ $VRNG $TGT $ES #sentiquant 20150424 18:00:09:935
lookn4wins
24 Apr 15 14:57:38
Do you follow $LOCK Click Here: http://t.co/hGhQXZmnrz Also See: $PFE $ABCB $IFON $VASC ~
Breaking News Now
24 Apr 15 14:24:04
$GE $MSFT $PFE $AAPL $IBM: Companies Leaving Trillions in Cash Overseas: http://t.co/LOxW7DX6rj
Jeff Sandene, CFP®
24 Apr 15 13:41:38
4/24/15 S&P 500: +0.23% GREEN: $SPY $DD $TXN $CMG $JNJ $DIS $MCD $PG $KR $SHW $LUV RED: $XOM $V $MA $M $WFC $JPM $BAC $IBM $PEP $PFE $KO $GE
				
				
By  +Follow July 30, 2013 8:52AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.